Inventor · disambiguated record
Martine Barth
Also filed as: BARTH MARTINE
18 granted patents·7 pending applications·124 citations·filing 1996–2021
92Inventor score
Top patents by PatentIndex Score
25 records- 0190US7361687B2Arylsulphonamide derivatives and methods of preparingFOURNIER LAB SA·Filed 2003·Granted Apr 22, 2008·62 cites·21 claims
- 0278US7795297B2Indole compounds, method of preparing them and uses thereofFOURNIER LAB SA·Filed 2008·Granted Sep 14, 2010·4 cites·11 claims
- 0375US7728002B2Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of conditions involving such receptorsFOURNIER LAB SA·Filed 2009·Granted Jun 1, 2010·2 cites·8 claims
- 0475US7557122B2Pyrrolopyridine compounds, method of making them and uses thereofFOURNIER LAB SA·Filed 2008·Granted Jul 7, 2009·2 cites·10 claims
- 0575US5968951ABenzenesulfonamide derivatives as bradykinin antagonistsFOURNIER IND & SANTE·Filed 1996·Granted Oct 19, 1999·19 cites·12 claims
- 0671US10414739B2Compounds as inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesotheliomaINVENTIVA·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 0771US6605633B1IL-8 receptor antagonistsFOURNIER IND & SANTE·Filed 2000·Granted Aug 12, 2003·7 cites·8 claims
- 0870US6479515B1Heterocyclic benzenesulphonamide compounds as bradykinine antagonistsFOURNIER IND & SANTE·Filed 2000·Granted Nov 12, 2002·5 cites·20 claims
- 0969US10106501B2Nuclear receptor modulatorsABBVIE INC·Filed 2016·Granted Oct 23, 2018·1 cites·53 claims
- 1069US2023066771A1Nuclear receptor modulatorsABBVIE INC·Filed 2021·Application pending·0 cites
- 1165US8436040B2Method of treating conditions involving PPAR-receptors with indole compoundsBINET JEAN·Filed 2010·Granted May 7, 2013·2 cites·3 claims
- 1265US2021130293A1Nuclear receptor modulatorsABBVIE INC·Filed 2019·Application pending·0 cites
- 1356US2019055196A1Nuclear receptor modulatorsABBVIE INC·Filed 2018·Application pending·0 cites
- 1446US11999758B2Inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of cancerINVENTIVA·Filed 2019·Granted Jun 4, 2024·0 cites·19 claims
- 1544US7538111B2Benzenesulphonamide derivatives, method for production and use thereof for treatment of painFOURNIER LAB SA·Filed 2004·Granted May 26, 2009·0 cites·8 claims
- 1644US6063791AN-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic useFOURNIER IND & SANTE·Filed 1997·Granted May 16, 2000·6 cites·12 claims
- 1742US6080758ABenzenesulfonamide derivatives as bradykinin antagonistsFOURNIER IND & SANTE·Filed 1996·Granted Jun 27, 2000·5 cites·12 claims
- 1841US9115151B2Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereofGEORGE DAWN M·Filed 2014·Granted Aug 25, 2015·0 cites·19 claims
- 1937US6384222B1N-benzenesulfonyl-L-proline compounds, preparation method and method for using the compounds in therapyFOURNIER IND & SANTE·Filed 1998·Granted May 7, 2002·3 cites·8 claims
- 2037US2005100902A15-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptorsFiled 2002·Application pending·0 cites
- 2137US2004138287A1Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptorsBARTH MARTINE·Filed 2002·Application pending·0 cites
- 2235US6211181B11-Benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonistsFOURNIER IND & SANTE·Filed 1996·Granted Apr 3, 2001·2 cites·7 claims
- 2335US6071917AN-benzenesulphonyl-L-proline derivatives as bradykinin B2 antagonistsFOURNIER IND & SANTE·Filed 1997·Granted Jun 6, 2000·2 cites·17 claims
- 2435US2004063725A1Novel n(phenylsulphonyl)glycine derivatives and their therapeutic useFiled 2002·Application pending·0 cites
- 2534US2020115353A1New compounds inhibitors of the yap/taz-tead interaction and their use in the treatment of malignant mesotheliomaINVENTIVA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martine Barth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →